Revenues for the quarter totaled $10.7 million, a 16 percent increase over last year's revenues of $9.2 million during the same quarter. Of total revenues, $4.4 million came from sales of Luminex instruments, $3.9 million from consumables, $1.2 million from royalties, and $1.1 million from other sources.
Research and development costs climbed to $1.5 million, up from $1 million during the year-ago quarter.
Luminex's net loss declined to $363,000, or $.01 per share, from $1.1 million, or $.04 per share, for last year's second quarter.
As of June 30, Luminex had $19.5 million in cash and cash equivalents, and $8.9 million in short-term investments.